Active Ingredients: Apixaban
Strength: 2.5 mg and 5 mg
Dosage Form: Tablet
Mechanism of Action: Factor Xa inhibitors
First Approval: US (Dec 28, 2012), EU (May 18, 2011)
Revenue1
Eliquis is a leading novel oral anticoagulant of BMS. The revenue for BMS continued to grow due to Eliquis and other recently launched new products. BMS and Pfizer jointly develop and…
